Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Changzhou Jialing Medicine Industry Co Ltd
WARNING LETTER
•Changzhou Jialing Medicine Industry Co Ltd

Changzhou Jialing Medicine Industry Co Ltd – FDA Warning Letter

Record Details

The FDA issued a Warning Letter to Changzhou Jialing Medicine Industry Co Ltd on December 29, 2011, due to the company's failure to fulfill drug establishment registration obligations under the Federal Food, Drug, and Cosmetic Act. The company continued to manufacture and import drugs into the U.S. in 2010 and 2011 without registering its establishment, despite being notified by the FDA on October 11, 2011.

This failure to register is a prohibited act under section 301(p) of the Act (21 U.S.C. § 331(p)). Additionally, drugs imported from an unregistered foreign establishment or not properly listed are subject to refusal of admission under sections 801(o) and 801(a)(3) of the Act, and may be deemed misbranded under section 502(o) for failure to list or update listing information.

The FDA requires Changzhou Jialing Medicine Industry Co Ltd to immediately register its establishment and properly list all drugs offered for import into the U.S. A written response detailing corrective actions must be submitted within fifteen working days of receiving the letter. If the company intends to cease importing drugs, it must notify the FDA and provide notice of discontinuance. Correspondence should be directed to Donovan F. Duggan at the Center for Drug Evaluation and Research/Office of Compliance. The

Company
Changzhou Jialing Medicine Industry Co Ltd
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Douglas Stearn
View Company Profile

ID · 91570dc3-5f50-4ffd-a03c-96c683631ed2

Violation Codes10
21 U.S.C. 360(i)(1)21 U.S.C. 331(p)21 CFR 20721 CFR 207.40(b)21 U.S.C. 381(o)21 U.S.C. 360(i)21 U.S.C. 381(a)(3)21 U.S.C. 352(o)21 CFR 207.30(a)21 CFR 207.25(b)(7)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Changzhou Jialing Medicine Industry Co Ltd
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.